Samukawa, Y., Haneda, M., Seino, Y., Sasaki, T., Fukatsu, A., Kubo, Y., . . . Sakai, S. (2018). Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment. Clin Pharmacol Drug Dev.

Samukawa, Yoshishige, Masakazu Haneda, Yutaka Seino, Takashi Sasaki, Atsushi Fukatsu, Yusuke Kubo, Yuri Sato, and Soichi Sakai. "Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment." Clin Pharmacol Drug Dev 2018.

Samukawa, Yoshishige, et al. "Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment." Clin Pharmacol Drug Dev 2018.